Central Venous Catheter Market Research, 2032
The global central venous catheter market was valued at $2.6 billion in 2022, and is projected to reach $4.7 billion by 2032, growing at a CAGR of 6.4% from 2023 to 2032. A central venous catheter (CVC) is an intravascular tube placed in large veins to complete the routine use of critical patients and major surgery patients. It is commonly used for critical patients and surgical procedures. The multi-lumen design of central venous catheters is intended for monitoring central venous pressure (CVP), blood sample collection, and simultaneous administration of multiple IV solutions or drugs.
Market Dynamics
The increase in incidences of accidents and the rise in the number of patients hospitalized for critical care boost the growth of the central venous catheters industry. Furthermore, the rise in the prevalence of kidney diseases and the increase in number of dialysis patients contributes to the growth of the Central Venous Catheter Market Size. For instance, according to American Kidney Fund, in 2020, more than 562,000 Americans were on dialysis. Central venous catheters are used for dialysis. Thus, the growth in number of hemodialysis drives the Central Venous Catheter Market Growth.
Moreover, the rise in the number of patients suffering from chronic diseases such as cancer and cardiovascular diseases is expected to create remunerative opportunities for the Central Venous Catheter Manufacturer. In addition, key players have adopted various strategies such as product launches, acquisitions, agreements, partnerships, and collaborations to strengthen their foothold in the Central Venous Catheter Industry. For instance, in June 2023, Merit Medical Systems, Inc., a leading global manufacturer and marketer of healthcare technology, announced the acquisition of the Surfacer Inside-Out access catheter system from Bluegrass Vascular Technologies, Inc. The Surfacer is a unique device designed to obtain right-sided central venous access in patients with venous obstructions, providing this population with access to life saving therapies including hemodialysis and chemotherapy.
The demand for central venous catheters is not only limited to developed countries but is also being witnessed in developing countries, such as China, Brazil, and India, which fuels the growth of the Central Venous Catheter Industry. Factors such as a rise in hospital admissions, an increase in the number of surgeries, and a surge in healthcare expenditures drive the growth of the market. In addition, an increase in incidences of accidents and emergency health conditions is expected to fuel the growth of the industry. However, the product recall by Central Venous Catheter Manufacturer hampers market growth.
Segmental Overview
The central venous catheter market is segmented into product type, property, design, end user, and region. On the basis of product type, the market is bifurcated into tunneled catheters and non-tunneled catheters. On the basis of property, the market is bifurcated into antimicrobial catheters and non-antimicrobial catheters. On the basis of design, the market is classified into single lumen, double lumen and multiple lumens. On the basis of end user, it is categorized into hospital, cancer treatment centers, and others. On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
By Product Type
On the basis of the product type, the market is bifurcated into tunneled catheters and non-tunneled catheters. The non tunneled catheter devices segment dominated the global Central Venous Catheter Market Sizein 2022 and is expected to remain dominant throughout the forecast period owing to an increase in the prevalence of kidney disorders and a rise in the incidences of accidents. Moreover, surge in geriatric population is anticipated to boost the demand for central venous catheter. This is attributed to the fact that aged individuals are highly susceptible to chronic diseases.
By Property
On the basis of property, the market is bifurcated into antimicrobial catheters and non-antimicrobial catheters. The non-antimicrobial catheters segment dominated the global Central Venous Catheter Market Share in 2022 and is expected to remain dominant throughout the forecast period owing to the lower cost of non-antimicrobial catheters and the rise in the number of patients who require dialysis.
By Design
On the basis of design, the market is classified into single lumen, double lumen and multiple lumens. The double lumens segment dominated the global Central Venous Catheter Market Share in 2022 and is expected to remain dominant throughout the forecast period owing to the advantages of double lumen catheters and the rise in the prevalence of cancer.
By End User
On the basis of end user, the market is divided into hospital, cancer treatment centers, and others. The hospital segment dominated the global market in 2022 and is anticipated to continue this trend during the Central Venous Catheter Market Forecast period. This is attributed to an increase in the adoption of central venous catheters in hospitals for critically ill patients. In addition, an increase in the number of surgeries in hospitals drives the growth of the market as the central venous catheter. Moreover, improvements in the healthcare infrastructure drive the growth of market.
By Region
On the basis of region, the central venous catheter market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In 2022, North America was the dominant region and is expected to continue this trend throughout the forecast period owing to high prevalence of chronic disorders such as kidney disorders and cancer, the strong presence of key players, and the surge in the number of critically ill patients in the region. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, owing to the presence of high population countries such as India and China, which, in turn, increases the prevalence of cardiovascular disorders and the growing number of strategies and trends adopted by the market players that include product development, product approval, partnership, collaboration, and agreement.
Competition Analysis
Competitive analysis and profiles of the major players in the central venous catheter market such as include AngioDynamics, Asahi Kasei Corporation., B. Braun Melsungen AG, Becton Dickinson and Company, ICU Medical, Medtronic Plc., Merit medical, Rex Medical, Teleflex Incorporated and Vygon Ltd. are provided in this report. These players have adopted product launch and product development as key developmental strategies to improve the product portfolio of the central venous catheter.
Recent Mergers in Central Venous Catheter Market
In June 2023, Merit Medical Systems, Inc., a leading global manufacturer and marketer of healthcare technology, announced the acquisition of the Surfacer Inside-Out access catheter system from Bluegrass Vascular Technologies, Inc.
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the central venous catheter market analysis from 2022 to 2032 to identify the prevailing Central Venous Catheter Market Opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the central venous catheter market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global central venous catheter market trends, key players, market segments, application areas, and market growth strategies.
Central Venous Catheter Market Report Highlights
| Aspects | Details |
 Market Size By 2032 | USD 4.7 billion |
 Growth Rate | CAGR of 6.4% |
 Forecast period | 2022 - 2032 |
 Report Pages | 250 |
 By Product type |
|
 By Property |
|
 By Design |
|
 By End-User |
|
 By Region |
|
 Key Market Players | Teleflex Incorporated, Asahi Kasei Corporation., Medtronic plc, Vygon, Merit Medical Systems Inc., B. Braun SE, AngioDynamics, Inc., Rex Medical, LLC., ICU Medical Inc., Becton, Dickinson and Company |
Analyst Review
Central venous catheter (CVC) is an intravascular tube placed in large veins to complete the routine use of critical patients and major surgery patients. Increase in the number of surgeries, and a rise in the incidences of accidents drives the market growth.
In addition, the strategies such as acquisition and merger adopted by key players contribute to the growth of the market. For instance, in January 2021, Shenzhen Prunus Technology Co., Ltd., acquired the critical care products division of Biosensors International Group, Ltd, officially entering the field of critical care consumables business. The products of acquired subsidiary include central venous catheters, pressure transducers, pulmonary artery catheters, pacing catheters, thrombolysis catheters, urinary catheters, and other medical consumables. Moreover, in June 2023, Merit Medical Systems, Inc., a leading global manufacturer, and marketer of healthcare technology, announced the acquisition of the Surfacer Inside-Out access catheter system from Bluegrass Vascular Technologies, Inc. The Surfacer is a unique device designed to obtain right-sided central venous access in patients with venous obstructions, providing this population with access to life-saving therapies including hemodialysis and chemotherapy.
The total market value of the central venous catheter Market is $2,571.2 million in 2022.
The forecast period in the report is from 2023 to 2032.
North America is the largest regional market for Central Venous Catheter
There are 10 central venous catheter manufacturing companies are profiled in the report
The top companies that hold the market share in AngioDynamics, Asahi Kasei Corporation., B. Braun, Becton Dickinson and Company, and ICU Medical
The base year for the report is 2022.
Yes, central venous catheter companies are profiled in the report/
Yes, the competitive landscape included in the central venous catheter market report.
Loading Table Of Content...
Loading Research Methodology...
